Inovio Pharmaceuticals, Inc(NASDAQ:INO) 
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely design...
Website: http://www.inovio.com
Founded: 1999
Full Time Employees: 190
CEO: J. Joseph Kim
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 1.56
H 1.58
L 1.50
C 1.56
V 608,133
10EMA 1.56
20EMA 1.56
60EMA 1.56
120EMA 1.56
250EMA 1.56